Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its always some unprovable entity that is responsible for the PPS. How about the complete lack of progress for a product that this company has spent 4+ years promoting. How about doubling the amout of shares in that same period with very little to show for it. How about setting timelines and then missing them every time. How about screwing up and not raising funds when the market was favorable. Who other then people that own this stock would even give this company a look when investing their money. Do a search on PMCB and nuvilex and act like you don't own the stock and know nothing about them and read the promotions and missed promises and the dates they were released.
I have emailed them several times expressing my disappointment with their lack of accomplishments and pay increases. Maybe if more shareholders did the same instead of patting KW on the back for issuing paid PR and giving himself a 30% raise he would start to feel the heat.
How low does the PPS need to go before investors of PMCB start pushing this company hard to accomplish something real. Instead of dreaming about Billion Dollar buyouts. I don't mean paperwork accomplishments like ODD either.
Its called an Interim Analysis and it is common practice. It is also used to stop trials for futility.
That's why I always get a great laugh when people quote wikipedia. An encyclopedia that anyone can edit. What a stupid idea.
Is Tim Matula still work for PMCB ?
I know they moved I just figured maybe they left that application back in Silver Springs by mistake.
Looking like another year wit no clinical trial. Timeline for filing pre-ind and Ind makes it almost impossible for a clinical trial to start this year. So let me understand. The chemistry is well known for CIAB it works with a drug that has been around for decades the trial design has been done for months and according to those in the know money is no problem and Doctors are lining up to be involved and PMCB is within walking distance to the FDA. Maybe someone should stop by and offer to bring that application over to the FDA.
And the first two were on previously untreated patients.
A total of 17 patients were enrolled in the trial between
July 1998 and April 1999 (
Table 1
) from the 51 patients
screened during the study period. Reasons for non-enrolment
were previous chemotherapy (n = 8), pancreatic surgery (n = 13),
poor general condition (n = 18), unwillingness to participate (n =
5), or death (n = 7). Criteria for entering the study included an
inoperable pancreatic adenocarcinoma stage III-IV (UICC)
(Hermanek et al, 1997), as determined by histology and
measured by CAT scan and only patients who had not received
prior chemotherapy were enrolled (Löhr et al, 1999). During the
I didn't say it won't work but there is not one credible Scientist Doctor or medical professional that would say it "absolutely does" work.
Please tell me your not serious saying it absolutely works. That is a complete guess on your part with no facts to back it up.
Is Patricia Gruden work for PMCB
No its not but it still has to go through the same process as drugs do.
Success rates for experimental drugs falls: study
The cancer drug success rate was a mere 4.7 percent, with cardiovascular drugs second-worst at 5.7 percent, as regulators are increasingly demanding proof that heart drugs reduce heart attacks and strokes rather than just lower a risk factor, such as cholesterol levels.
It is not surprising that from conception to market most compounds face an uphill battle to become an approved drug. For approximately every 5,000 to 10,000 compounds that enter preclinical testing, only one is approved for marketing
I am talking about the human trials from 1999 not mice trials. I would guess 95% of every treatment that does great in mice trials fails in human trials.
The FDA can't approve something that has not been requested
He knows it works? No one knows if it works until it gets into a trial on human beings. And no i don't count a small trial that even PMCB had to admit was statistically insignificant.
Wiki is now a legit source of information? A site that lets anyone edit its content. If Dr. Von Hoff contacted PMCB it was because someone (crabtree) sent him info because why else would the worlds leading researcher for PC not know about clinical data that was around for 15 years? Anyway the real question is when is Kenny Esq going to break the news that there will be no trials this year? It is almost the middle of Sep and not even a Pre-Ind has been requested.
He liked the data that was out there for 15 years and all of a sudden one day said I should contact Nuvilex. I would like that statement to come out of Dr. Von Hoff's mouth not KW and Crabtree.
No he does not. PMCB has four employees (three if you eliminate Prof. Walter H. Günzburg who really works for Austrianova)
1-Kenny Esq.
2-Crabtree
3-Mr. Carlos A. Trujillo
No Dr. Von Hoff works for tgen. Currently he is working on several projects not related to PMCB. They are written about and sent to donors every few months.
Austrianova helping PMCB with finance ? Austrianova would not even be in business without $2,000,000 payment for the MJ rights form PMCB. Does Austrianova have even one product that generates cash ?
Thats it! A couple of ODD designations? They give them out like business cards at the FDA now. They mean nothing unless your treatment passes every phase of clinical trails there are something like 500 ODD designations for treatments out there right now. There is a tiny bio that has 5 of them for the same treatment in different cancers and there market cap is the same as PMCB. Patents for a cell line that belongs to the University of Technology Sydney and has not even been proven to do anything.
The only one's suppressing this stock are the two leaders KW and Crabtree and their total lack of accomplishing anything. This stock has been circling the bowl for two years now because nothing is being done. It doesn't and shouldn't take this long to get to trials with a product that has already been in trials.
Exactly what short interest are you talking about? Please find me one financial website that shows any short interest in this company.
They have had about 1460 overnights since acquiring this technology I think that's more then enough time.
What operations are you talking about? They have KW and Crabtree and i am sure that both of them spent zero hours in the office last year.
It also has no money, no clinical trials, and every aspect of the company is dependent on outside contractors.
How does a statement like "obviously works" make any sense?
You are correct most would take .25 the problem is no one would offer .025. I will say again the "big pharma" beat down theory is ridiculous. Big pharma has no problem paying and in most cases over paying for technology they want.
Yes it is meaningless for a company that has no money to be spending one nickle on something they have not even done preliminary research on. A company that can't fund its trial that it has been promising for 4 years now. And its not their license it belongs to the University of Northern Colorado.
I have to agree with that. TD2 is not in the business of telling companies not to develop treatments. They are in business to provide a service that the company wants them to not to pass judgment on what is good or bad. Their reputation will not be affected in any way.
A good CEO would know you don't try and do everything when you barely have the money to pay the daily bills. Do you think someone was going to swoop up the rights for MJ? Building a portfolio for a buyout? How about proving the technology works first.
Wouldn't have been nice if some of the money wasted by KW on things like $2,000,000 paid to Austrianova for CIAB for MJ was still in the bank or the countless $millions spent on who knows what. Or maybe if the great KW had raised money when the PPS was .20 using the ATM. Now we get to watch him try and raise money in the weakest possible position to fund trials.
So now the message is that if no one funds their trial there won't be one? I would say that is a very large problem.
So if no outside funding is found for trials there will be no trials?
I don't see how anyone can think they have enough money for clinical trials. Its not just the cost of treating the patients in the trial. It is the cost of filing the IND and the cost of training at every site for implanting the cells and imaging.
What you make has nothing to do with what I posted. I am talking about taking $16,000 a month salary while his investors have watched the PPS drop like a cinder block over the past two years. While he has been selling shares at .02 to raise money just to keep the lights on. While he has not invested one penny of his own money to show how much he believes in the company. He will make plenty of money if the clinical trial goes well and should. right now i see two guys past retirement age making dam good money in a company that only has 3 employees and not willing to put on penny of their own money on the line and that shouldn't sit well with any investor of this company.
Receiving a paycheck of $16,000 a month i don't think speed is what KW is looking for.
Really
You need to have a Principle Investigator BEFORE you meet with the FDA.
You need to have a pre-ind meeting 2-3 months before an ind meeting.
You need request a pre-ind 60 days before you have one.
Its September next week not March.